Viatris Reports Fourth-Quarter and Full-Year **** Financial Results
U.S. FDA Accepts Viatris Supplemental New Drug Application for Investigational Presbyopia Treatment, Sets PDUFA Goal Date
Viatris Appoints Matthew J. Maletta as Chief Legal Officer
Four Recent Regulatory Milestones Span Across All Stages of Viatris' Global Pipeline
We believe in healthcare as it should be - empowering people worldwide to live healthier through every stage of life.
We produce high quality medicines across a range of therapeutic areas spanning both noncommunicable & infectious diseases.
We are excited about who we are and the work we do every day, ensuring access to health for patients everywhere.
#J-*****-Ljbffr